SILVER
SPRING, Md., July 5, 2024
/PRNewswire/ -- Today, the U.S. Food and Drug Administration is
providing an at-a-glance summary of news from around the
agency:
- On Wednesday, the FDA updated the advisory for the
investigation of Salmonella illnesses linked to cucumbers.
The FDA and CDC, in collaboration with state and local partners,
are investigating a multistate outbreak of Salmonella
Africana and Salmonella Braenderup infections with 449
illnesses in 31 states and the District
of Columbia. While originally reported as two separate
outbreaks, CDC and FDA combined these two outbreak investigations
as they shared several similarities, including when and where
illnesses occurred, the demographics of ill people, and the foods
they reported eating before they became sick. Laboratory,
epidemiological, and traceback data have determined that cucumbers
from Bedner Growers, Inc., of Boynton
Beach, Florida, are a likely source of illnesses in this
outbreak; however, this grower does not account for all the
illnesses in this outbreak. Bedner Growers, Inc.'s cucumber growing
and harvesting season is over. There is no product from this farm
on the market and likely no ongoing risk to the public.
- On Tuesday, the FDA announced a public workshop entitled
Food and Drug Administration/National Institutes of Health
Joint Workshop: Developing Implanted Brain-Computer Interface
Clinical Outcome Assessments to Demonstrate Benefit that
will be held on Thursday, September
19 and Friday, September 20,
2024. The purpose of this public workshop is to discuss
implanted brain-computer interface devices, to engage with
stakeholders in the implanted brain-computer interface device
ecosystem, and to discuss the development of clinical outcome
assessments to evaluate the effectiveness of implanted
brain-computer interfaces. The registration deadline is
September 12, 2024. This is a hybrid
workshop being held at the FDA's White Oak Campus in Silver Spring, MD, and webcast.
- On Tuesday, the FDA updated the advisory for the investigation
of illnesses linked to Diamond Shruumz-brand products. As of
July 1, 2024, a total of 48 illnesses
have been reported from 24 states. Forty-six people have reported
seeking medical care; twenty-seven have been hospitalized. There is
one potentially associated death under investigation. Consumers
should not eat, sell, or serve any flavor of Diamond Shruumz-brand
Chocolate Bars, Cones, or Gummies.
Additional Resources:
# # #
Media Contact: FDA Office of Media Affairs,
301-796-4540
Consumer Inquiries: 888-INFO-FDA
The FDA, an agency within the U.S. Department
of Health and Human Services, protects the public health by
assuring the safety, effectiveness, and security of human and
veterinary drugs, vaccines and other biological products for human
use, and medical devices. The agency also is responsible for the
safety and security of our nation's food supply, cosmetics, dietary
supplements, radiation-emitting electronic products, and for
regulating tobacco products.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/fda-roundup-july-5-2024-302190229.html
SOURCE U.S. Food and Drug Administration